Results 211 to 220 of about 18,680 (257)

Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025. [PDF]

open access: yesEndocr J
Tanabe A   +22 more
europepmc   +1 more source

Release of HMGB1 from human-derived cancer and normal cells by internal targeted radiotherapy with 131I-meta-iodobenzylguanidine. [PDF]

open access: yesJ Radiat Res
Sato K   +11 more
europepmc   +1 more source

MIBG Scintigraphy and Arrhythmic Risk in Myocarditis. [PDF]

open access: yesBiomedicines
Lo Monaco M   +7 more
europepmc   +1 more source

Polymer‐supported radiopharmaceuticals: [131I]MIBG and [123I]MIBG

Journal of Labelled Compounds and Radiopharmaceuticals, 1999
A new method has been developed that produces no-carrier-added [131I]MIBG in ≥90% radiochemical yield and high chemical purity. Isolation and purification are simple involving just filtration and absorption and desorption onto a C18 Sep-Pak™ cartridge.
Duncan H. Hunter, Xizhen Zhu
openaire   +2 more sources

I-131-MIBG therapies

Methods, 2011
Metaiodobenzylguanidine (MIBG) is a tracer that selectively targets neuroendocrine cells. On this basis, radiolabeled iodinated-MIBG (I-131-MIBG) has been introduced as a molecular nuclear therapy in the management of neuroendocrine tumors, including neuroblastoma, pheochromocytoma, paraganglioma, neuroendocrine carcinomas, and other rare ...
Voo, S., Bucerius, J., Mottaghy, F.M.
openaire   +2 more sources

False positive MIBG scan

Medical and Pediatric Oncology, 1997
The fortuitous discovery of a left posterior cervico-mediastinal mass during hospitalization for hemolytic anemia in an 18 month old baby is reported. Metaiodobenzylguanidine (MIBG) uptake suggested a sympathetic tissue origin of the mass despite negative catecholamines excretion, but histopathologic examination revealed a juvenile capillary angioma ...
D, Frappaz   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy